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Cohort studies of children during the 1980s in
North America, Europe, and Australia docu-
mented that blood lead concentrations of at
least 10 µg/dL are inversely associated with cog-
nitive test scores in children (Needleman and
Gatsonis 1990; Pocock et al. 1994; Schwartz
1994). These ﬁndings led to the 1991 revision
of the Centers for Disease Control and
Prevention’s (CDC) deﬁnition of an elevated
blood lead concentration, which was lowered
from 25 to 10 µg/dL (CDC 1991).
Accumulating evidence since 1991 sug-
gests that children’s intellectual ability is
adversely affected at blood lead concentrations
< 10 µg/dL (Bellinger and Needleman 2003;
Canfield et al. 2003a, 2004; Chiodo et al.
2004; Lanphear et al. 2000, 2005; Schnaas
et al. 2006; Schwartz 1994; Surkan et al. 2007;
Tellez-Rojo et al. 2006). To examine some of
this evidence in detail, a working group
(Weitzman et al. 2004) was convened by the
CDC, and the fifth revision of the CDC’s
Preventing Lead Poisoning in Young Children
was issued in 2005 (CDC 2005b). The work-
ing group concluded that the “overall weight
of evidence supports an inverse association
between blood lead levels < 10 µg/dL and the
cognitive function of children,” with the caveat
that the available data were limited by the
small number of “directly relevant cohort
studies”—studies that include multiple meas-
ures of lead exposure throughout early life and
key covariate information to reduce the poten-
tial for residual confounding (CDC 2005b).
Despite the conclusions reached by the work-
ing group, the CDC deﬁnition of an elevated
blood lead level was not lowered at that time
(CDC 2005b). 
This report, based on a prospective study
that includes eight measures of children’s
blood lead concentrations from 6 months to
6 years of age and that includes measures of
key potential confounders in the lead–IQ
relation, meets the criteria for a study that is
directly relevant to assess questions of possible
cognitive effects of lead exposure at blood
lead concentrations < 10 µg/dL.
Methods
Sample selection. Children participating in
the current study were born between July
1994 and January 1995 and were recruited at
24–30 months of age from a previous trial of
276 children enrolled ﬁrst at 6 months of age
(Lanphear et al. 1999). Children and their
families were eligible for the dust-control trial
if they lived in Rochester, New York, had no
plans to relocate in the next 3 months, and
the children were between 5 and 7 months of
age at the time of the baseline visit. For the
current study of lead exposure and cognitive
functioning, we excluded low birth weight
(< 2,500 g) and preterm (< 37 weeks of gesta-
tion) infants, two children with Down
syndrome, and one child whose primary lan-
guage was not English, resulting in 242 chil-
dren eligible for the current study. At 6 years
of age, 194 children (80%) participated; chil-
dren and parents not participating either
moved or could not be located, declined par-
ticipation or repeatedly missed appointments,
or the child had died before this assessment.
The Institutional Review Board at the
University of Rochester Medical Center
approved the study, and all parents or
guardians provided written informed consent.
Collection and analysis of blood samples.
Venous blood samples were collected when
children were 6, 12, 18, and 24 months of
age during the dust-control study, and at 36,
48, 60, and 72 months of age during the cur-
rent study of cognitive functioning. All col-
lection tubes and needles that were used for
specimen collection were provided by the
analyzing laboratory, where they were pre-
checked by lot number to ensure the absence
of any background lead contamination (i.e.,
< 0.5 µg/dL). All analytical measurements for
blood lead were carried out in the Wadsworth
Center’s Lead Poisoning and Trace Elements
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BACKGROUND: Few studies provide data directly relevant to the question of whether blood lead
concentrations < 10 µg/dL adversely affect children’s cognitive function. 
OBJECTIVE: We examined the association between blood lead concentrations assessed throughout
early childhood and children’s IQ at 6 years of age.
METHODS: Children were followed from 6 months to 6 years of age, with determination of blood
lead concentrations at 6, 12, 18, and 24 months, and 3, 4, 5, and 6 years of age. At 6 years of age,
intelligence was assessed in 194 children using the Wechsler Preschool and Primary Scale of
Intelligence–Revised. We used general linear and semiparametic models to estimate and test the
association between blood lead concentration and IQ.
RESULTS: After adjustment for maternal IQ, HOME scale scores, and other potential confounding
factors, lifetime average blood lead concentration (mean = 7.2 µg/dL; median = 6.2 µg/dL) was
inversely associated with Full-Scale IQ (p = 0.006) and Performance IQ scores (p = 0.002).
Compared with children who had lifetime average blood lead concentrations < 5 µg/dL, children
with lifetime average concentrations between 5 and 9.9 µg/dL scored 4.9 points lower on Full-Scale
IQ (91.3 vs. 86.4, p = 0.03). Nonlinear modeling of the peak blood lead concentration revealed an
inverse association (p = 0.003) between peak blood lead levels and Full-Scale IQ down to
2.1 µg/dL, the lowest observed peak blood lead concentration in our study.
CONCLUSIONS: Evidence from this cohort indicates that children’s intellectual functioning at
6 years of age is impaired by blood lead concentrations well below 10 µg/dL, the Centers for
Disease Control and Prevention deﬁnition of an elevated blood lead level.
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established method based on electrothermal
atomic absorption spectrometry (ETAAS)
(Parsons and Slavin 1993). The Wadsworth
Center’s Lead Poisoning and Trace Elements
Laboratory is the New York State reference
laboratory for this assay and is responsible for
operating the New York State Proficiency
Testing Program for Blood Lead. It is also a
reference laboratory for the blood lead proﬁ-
ciency testing programs operated by the states
of Wisconsin and Pennsylvania. 
The analytic procedure for lead determina-
tion was as follows: Whole blood was diluted
1:9 with phosphate modifier, and a 12-µL
aliquot was injected into a Model 4100ZL
atomic absorption spectrometer equipped with
a transverse-heated graphite atomizer (THGA)
and a longitudinal Zeeman-effect background
correction system (PerkinElmer Life and
Analytical Sciences, Shelton, CT). The THGA
instrument was calibrated daily before each
run with aqueous lead standards traceable to
the National Institute of Standards and
Technology (NIST, Gaithersburg, MD).
Three concentrations of New York State
Department of Health (Albany, NY) blood-
based reference materials (including one
< 10 µg/dL) were analyzed before, during, and
after each analytical run as part of the labora-
tory’s internal quality assurance program
(Parsons et al. 2001). Additional quality assur-
ance validation was obtained through periodic
analysis of NIST Standard Reference Material
955a/b Lead in Bovine Blood. The ETAAS
analytical method has also been cross-validated
against a method based on inductively coupled
plasma mass spectrometry (Palmer et al.
2006). All specimens were analyzed in dupli-
cate (independent aliquots), with three furnace
injections per analysis. An average lead con-
centration was calculated across injections for
each aliquot by the spectrometer, and the two
aliquot means were averaged to derive the lead
concentration used in analyses. The method
detection limit is estimated at 1.0 µg/dL and
the limit of quantitation is approximately
3 µg/dL, based on the International Union of
Pure and Applied Chemistry harmonized deﬁ-
nitions. Repeatability—the day-to-day preci-
sion expressed as a standard deviation—ranged
from 0.1 to 0.3 µg/dL at blood lead concentra-
tions < 10 µg/dL based on duplicate measure-
ments over 5 days, whereas it was < 2% above
20 µg/dL. Child’s iron status at 6 years of age
was measured by serum transferrin saturation
at Rochester General Hospital laboratories.
Assessment of intelligence. Children were
administered the Wechsler Preschool and
Primary Scale of Intelligence, Revised,
(WPPSI-R) during their 6-year visit at the
Rochester General Hospital in Rochester by an
examiner trained in pediatric neurobehavioral
testing (Brandt and van Gorp 1999). The
WPPSI-R was chosen because it provides a
thorough sampling of abilities for children with
lower than average IQ test scores (Sattler 2001).
Children were administered ﬁve subtests requir-
ing visual–spatial skills (Object Assembly,
Geometric Design, Block Design, Mazes, and
Picture Completion) and ﬁve subtests requiring
verbal skills (Information, Comprehension,
Arithmetic, Vocabulary, and Similarities).
Combining the scores for all 10 subtests yields
the Full-Scale IQ, a global measure of intelli-
gence. Combining the scores for the five
visual–spatial subtests yields a Performance IQ;
the five verbal subtests yield a Verbal IQ.
Ninety-two percent of children with complete
data were tested between 72 and 75 months of
age (range, 72–80 months), and 156 children
(90%) completed all 10 Performance and
Verbal IQ subtests. We calculated prorated IQ
scores for the remaining 18 children who com-
pleted 8 or 9 of the 10 subtests (Sattler 2001;
Wechsler 1989). The same examiner conducted
all assessments and was unaware of each child’s
blood lead concentration.
Blood lead measures. We constructed four
exposure variables from the eight blood lead
measures: a) lifetime average blood lead con-
centration, computed by dividing the total area
under each child’s age-by-blood-lead curve by
66 (72 months – 6 months); b) concurrent
blood lead concentration, the blood lead con-
centration measured on the day of cognitive
testing at 6 years of age; c) infancy average
blood lead concentration (area under the
child’s age-by-blood-lead curve from 6 to
24 months); and d) peak blood lead concentra-
tion, the child’s highest measured blood lead
concentration from 6 months through 6 years
of age. We used conditional means regression
to impute 131 missing age-speciﬁc blood lead
measures (9% of a total of 1,392) before con-
struction of the lead exposure variables.
Covariate measures. At each semiannual
visit, a parent or guardian was interviewed to
obtain information about their child’s medical
history and demographic information about
the respondent, child, and his or her family.
Birth records provided data on perinatal fac-
tors including parity, birth weight, and gesta-
tional age at birth. The Home Observation for
Measurement of the Environment Inventory
(HOME) (Caldwell and Bradley 1984) was
administered in the child’s home when the
child was 24 months of age, and the HOME-
Short Form (HOME-SF) (Center for Human
Resource Research 1992) was completed by
the child’s parent or guardian during the inter-
view at 6 years of age. The HOME-SF has
been used with minor modiﬁcations in large-
scale U.S. longitudinal assessments with good
concurrent and predictive validity of vocabu-
lary and achievement test scores (Baker et al.
1993; Bradley et al. 2001). Maternal IQ was
assessed during the child’s visit at 3 years of
age using the Stanford-Binet IV screening bat-
tery (Thorndike et al. 1986). 
Statistical analyses. Linear analyses. We
estimated the association between each lead
exposure measure (lifetime average, concurrent,
infancy average, and peak) and each WPPSI-R
IQ score (Full-Scale, Performance, and Verbal
IQ). Blood lead was modeled categorically to
reduce the inﬂuence of outlying blood lead val-
ues and to demonstrate differences in mean IQ
across blood lead groups. Categories were
defined as < 5 µg/dL (reference), 5.0–9.9
µg/dL, and ≥ 10 µg/dL for lifetime average,
concurrent, and infancy average blood lead
concentration. Because of the greater range of
values for peak blood lead, concentrations ≥ 10
µg/dL were divided further into two categories:
10.0–14.9 µg/dL and ≥ 15.0 µg/dL. These nat-
ural categories were chosen for their potential
relevance to decision making in clinical and
health policy settings and to ensure adequate
numbers of subjects in each category. We pre-
speciﬁed a general linear model that included
the same predictors of child IQ that had been
selected a priori and used in a previous report
from this cohort (Canﬁeld et al. 2003a; Jusko
et al. 2005). In addition to blood lead as a clas-
siﬁcation factor, the regression model included
classiﬁcation factors for yearly family income
measured when the child was 6 years of age
(<$10,000, $10,000–24,999, $25,000–50,999,
or ≥ $51,000); child’s sex; mother’s highest
reported level of education during the
66-month follow-up (< 12 years, 12 years, or
> 12 years), race (self-identified as white or
nonwhite), and prenatal smoking (yes/no); and
covariates birth weight, transferrin saturation,
mother’s IQ, and the HOME-SF total score at
6 years of age. The same model was used for all
analyses regardless of the dependent variable.
Prespeciﬁed contrasts for differences in adjacent
blood lead groups were estimated and tested to
describe the incremental change in IQ across
blood lead categories. We also speciﬁed a model
identical to the primary model except that the
categorized blood lead variable was regarded as
quantitative. The 1-degree-of-freedom test of
this variable can be regarded as a test of trend
and is presented for each of the 12 blood
lead–IQ combinations (4 blood lead measures
× 3 IQ measures). Statistical analyses were con-
ducted using SAS software (version 9.1; SAS
Institute Inc., Cary, NC), and all statistical tests
were two-sided, with a p-value < 0.05 indicat-
ing statistical signiﬁcance.
Nonlinear analysis. Because of our previous
research indicating a nonlinear dose–response
relation and conﬁrmation of this in the analy-
ses in which lead measures are modeled cate-
gorically, we conducted a secondary analysis
of peak blood lead levels in relation to
Full-Scale IQ. This analysis also makes full use
of the quantitative nature of the measured lead
concentrations. We modeled peak blood lead as
Jusko et al.
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variable helps answer the public health question
of setting a maximum allowable blood lead
concentration for developing children. 
We estimated the dose–response relation
using a generalized additive model (GAM),
employing a locally weighted scatterplot
smooth (LOESS) on the quantitative peak
blood lead variable. This model was imple-
mented in SAS version 9.1 (SAS Institute Inc.)
using the GAM procedure, specifying a LOESS
smoother with 2 degrees of freedom. This semi-
parametic GAM model allowed us to adjust
parametrically for the same covariates used in
the linear analyses and at the same time esti-
mate the association between peak blood lead
concentrations and IQ nonparametically. We
truncated the top 3% of peak blood lead values
(ﬁve values between 33.6 and 45.7 µg/dL) to
ensure that the shape of the dose–response rela-
tion was not inﬂuenced by outlying values.
Results
Sample characteristics. Of the 194 children
and families participating when the child was
6 years of age, 174 had complete information
on all explanatory variables and are included
in the results described below. Table 1 com-
pares characteristics of children and their fam-
ilies with complete data (n = 174), those with
missing covariate information (n = 20), and
those not participating at 6 years (n = 48).
Except for maternal IQ, characteristics among
the three groups were similar.
Blood lead concentrations. Distributions of
each blood lead measure are given in Figure 1.
The figure indicates that for no fewer than
75% of children, the lifetime average, concur-
rent, and infancy average blood lead measures
were < 10 µg/dL, and the median blood lead
concentration for all lead exposure variables
was < 10 µg/dL. Speciﬁcally, lifetime average
blood lead had a mean of 7.2 µg/dL (median,
6.2 µg/dL; range, 1.4–27.1 µg/dL), with
77% of children averaging < 10 µg/dL through
6 years of age. At the 6-year assessment,
concurrent blood lead concentrations aver-
aged 5.0 µg/dL (median, 4.0 µg/dL; range,
1.1–23.7 µg/dL) and 92% of children
had measured blood lead concentrations
< 10 µg/dL. Infancy average blood lead had a
mean of 7.1 µg/dL (median, 6.5 µg/dL; range,
0.7–28.7 µg/dL), with 81% of children averag-
ing < 10 µg/dL for that period. Children’s peak
blood lead concentration averaged 11.4 µg/dL
(median, 9.4 µg/dL), and ranged from 2.1 to
45.7 µg/dL. Fifty-ﬁve percent of children never
had a measured blood lead concentration
≥ 10 µg/dL from 6 to 72 months of age.
Intelligence test results. The mean (± SD)
Full-Scale IQ score at 6 years of age was
85 ± 14 (range, 55–146), consistent with pre-
vious IQ assessments in this cohort (Canﬁeld
et al. 2003a). Full-Scale IQ scores at 6 years of
age were correlated with maternal IQ scores
(r = 0.52, p < 0.001), and with the children’s
own scores on the Stanford-Binet IV, previ-
ously administered at 3 and 5 years of age
(Canfield et al. 2003a) (r = 0.74, p < 0.001;
and r = 0.82, p < 0.001, respectively), at mag-
nitudes consistent with the standardization
samples for these instruments (Sattler 2001).
Blood lead concentrations and IQ.
Lifetime average blood lead concentration.
After covariate adjustment, lifetime average
blood lead concentration was inversely associ-
ated with Full-Scale (p = 0.006 for trend) and
Performance IQ (p = 0.002 for trend) and
marginally associated with Verbal IQ (p = 0.11
for trend) (Figure 2). Compared with children
who had lifetime average blood lead concentra-
tions < 5 µg/dL, children with lifetime average
blood lead concentrations between 5 and 9.9
µg/dL scored 4.9 points lower on Full-Scale IQ
(91.3 vs. 86.4, p = 0.03) and 4.9 points lower
on Performance IQ (92.3 vs. 87.4, p = 0.03)
(Figure 2). Mean Full-Scale IQ scores were 2.3
points lower among children with lifetime
average blood lead concentrations ≥ 10 µg/dL
than children with lifetime average blood lead
concentrations between 5 and 9.9 µg/dL, but
this difference was not significant (86.4 vs.
84.1, p = 0.34). A similar pattern was noted for
Performance IQ (87.4 vs. 83.7, p = 0.13).
Concurrent blood lead concentration. A
dose–response relation also was observed
between concurrent blood lead concentrations
and Full-Scale and Performance IQ (p = 0.03
and p = 0.004 for trend, respectively), but not
with Verbal IQ (p = 0.28 for trend) after
adjustment (Figure 3). The estimated Full-
Scale IQ for children with concurrent blood
lead concentrations between 5 and 9.9 µg/dL
was 3.7 points lower than for children with
concurrent blood lead concentrations < 5 µg/dL
(89.6 vs. 85.9, p = 0.10), and 3.2 points
higher than estimated for children with con-
current blood lead concentrations ≥ 10 µg/dL
(85.9 vs. 82.7, p = 0.37). For Performance IQ,
children with concurrent blood lead concen-
trations between 5 and 9.9 µg/dL scored an
average of 5.5 points lower than children with
concurrent blood lead concentrations < 5 µg/dL
(91.0 vs. 85.4, p = 0.01), but the estimated
Performance IQ for children with concurrent
blood lead concentrations ≥ 10 µg/dL was
only 2.7 points lower than children with con-
current blood lead concentrations between
5 and 9.9 µg/dL (85.4 vs. 82.7, p = 0.45).
Blood lead and IQ
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Table 1. Characteristics of children, mothers, and families when the child was 6 years of age.
Children with Children with Not participating
complete data incomplete data at 6 years
Characteristic (n = 174) (n = 20)a (n = 48)
Children
Female sex (%) 50 45 62
Birth weight (g) 3,301 ± 422 3,460 ± 439 3,293 ± 497
Weeks of gestation 39.5 ± 1.2 39.8 ± 0.7 39.5 ± 1.3
Full-scale IQ 85.4 ± 14.4 84.8 ± 12.6 —
Lifetime average blood lead (µg/dL) 7.2 ± 4.1 6.2 ± 4.0 6.6 ± 2.8
Concurrent blood lead (µg/dL) 5.0 ± 3.3 4.1 ± 3.1 —
Infancy average (µg/dL) 7.1 ± 3.9 6.8 ± 4.0 6.8 ± 3.8
Peak blood lead (µg/dL) 11.4 ± 7.3 11.4 ± 9.1 10.2 ± 5.7
Transferrin saturation (%) 20.7 ± 8.6 16.1 ± 6.3 —
Mothers
Age at delivery (years) 24.8 ± 6.6 25.2 ± 5.5 24.4 ± 5.3
Number of prenatal visits 11.2 ± 4.2 10.5 ± 4.4 9.9 ± 3.4
Smoked during pregnancy (%) 24 26 26
Nonwhite race (%) 74 50 67
IQ* 81.6 ± 12.6 93.9 ± 12.5 84.2 ± 9.8
Education (years) 12.3 ± 1.9 12.3 ± 2.0 —
Household income [US$ (%)]
< 10,000 28 28 —
10,000 – 24,999 45 22 —
25,000 – 50,999 21 28 —
≥ 51,000 6 22 —
HOME-SF total score  11.3 ± 2.5 11.7 ± 2.7 —
Data are presented as mean ± SD unless otherwise indicated. Mean differences across groups tested with chi-square,
analysis of variance, and Kruskal–Wallis tests respectively, for categorical, interval, and ordinal variables. 
aData missing for some characteristics and some study participants. *p < 0.05 for comparison between children with
complete data (n = 174) and children with incomplete data (n = 20).
Figure 1. Distributions of blood lead concentrations
(n = 174). In each box plot, the median value is indi-
cated by the center horizontal line and the 25th and
75th percentiles are indicated by the lower and
upper horizontal lines, respectively. The vertical
lines represent the 5th and 95th percentiles.
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Adjusted Full-Scale and Performance IQ scores
were associated with infancy average blood lead
concentrations (p = 0.05 and 0.02 for trend,
respectively) (Figure 4). However, there was no
significant association of Verbal IQ with
infancy average blood lead (p = 0.34 for trend).
Consistent with results from the lifetime aver-
age and concurrent blood lead measures, a
dose–response function was observed, with
larger Full-Scale and Performance IQ decre-
ments occurring between blood lead categories
< 5 µg/dL and 5–9.9 µg/dL than between
blood lead categories 5–9.9 µg/dL and
≥ 10 µg/dL (Figure 4). Notably, children with
infancy average blood lead concentrations
between 5 and 9.9 µg/dL scored 5.2 points
lower on Full-Scale IQ (91.1 vs. 85.9, p = 0.02)
and 5.4 points lower on Performance IQ (92.2
vs. 86.7, p = 0.01) than did children with
infancy average blood lead concentrations
< 5 µg/dL.
Peak blood lead concentrations. Both Full-
Scale and Performance IQ exhibited a
dose–response relation with peak blood lead
concentration. Again, lower IQ scores were
associated with higher peak blood lead concen-
trations (p = 0.03 and p = 0.02 for trend,
respectively). Verbal IQ exhibited a less consis-
tent trend with peak blood lead concentration
(p = 0.19 for trend) (Figure 5). Comparing esti-
mated Full-Scale IQ across the four peak blood
lead categories, the difference between blood
lead category 1 and 2 was 5.6 IQ points (93.9
vs. 88.3, p = 0.09), but only a 2.3-point IQ dif-
ference was observed comparing groups 2 and 3
(88.3 vs. 85.9, p = 0.33), and an even smaller
difference was observed comparing groups 3
and 4 (85.9 vs. 85.2, p = 0.79). A similar
pattern was observed for Performance IQ. 
Peak blood lead concentration and IQ:
Nonlinear function. A plot of the nonlinear
relation between peak blood lead and Full-Scale
IQ is shown in Figure 6. An inverse association
(p = 0.003) between the child’s maximum
(peak) blood lead concentration and Full-Scale
IQ was apparent down to 2.1 µg/dL, the lowest
measured peak concentration in our sample.
Further, the slope of the blood lead–IQ relation
was steeper at lower than at higher levels of
exposure. For instance, IQ decreased by
approximately 1.2, 0.32, and 0.15 points per
1-µg/dL increase in peak blood lead over the
range of 2.1–10 µg/dL, 10–20 µg/dL, and
20–30 µg/dL, respectively. 
Discussion
The ﬁndings of this study are directly relevant
to the question of whether blood lead concen-
trations < 10 µg/dL adversely affect children’s
cognitive functioning: Blood lead was measured
on up to eight occasions during infancy and
early childhood; the lifetime average blood lead
concentration was 7.2 µg/dL, and more than
half of the children never had a measured blood
lead concentration of ≥ 10 µg/dL; we gathered
extensive information about inﬂuences other
than lead exposure that are known to affect
intellectual development; and we assessed intel-
ligence at an age when IQ is measured reliably
and is a strong predictor of intelligence during
adolescence and adulthood. The results show
that childhood blood lead concentrations are
inversely related to IQ scores, whether lead
exposure is measured by lifetime and infancy
average measures, maximal (peak) exposure, or
on the same day the IQ test is administered.
This pattern of ﬁndings is most apparent for
the Full-Scale and the Performance IQ scores.
In particular, children with blood lead concen-
trations in the 5–9.9 µg/dL range had signiﬁ-
cantly lower IQ scores than children who had
blood lead concentrations < 5 µg/dL. Further,
additional nonlinear analysis of peak exposure
throughout early childhood indicated that
blood lead levels as low as about 2 µg/dL may
be associated with declines in Full-Scale IQ.
These findings also add to the body of evi-
dence that the effect of blood lead on child
intellectual development is larger for equal
increments of lead < 10 µg/dL than it is at
higher levels.
The analytic approach in this study
allowed for direct comparisons between chil-
dren with blood lead concentrations < 5 µg/dL
with those who had levels > 5 µg/dL but still
below the CDC deﬁnition of an elevated blood
lead level (i.e., 5–9.9 µg/dL). The declines in
IQ observed with this approach reinforce the
conclusions of previous findings from this
cohort (Canfield et al. 2003a, 2003b, 2004;
Lanphear et al. 2005) that children are
adversely affected by blood lead concentrations
< 10 µg/dL. Findings from the current investi-
gation also extend the previous findings by
demonstrating that the low-level associations
reported at 3 and 5 years of age are not speciﬁc
to a particular IQ test. Whereas the Stanford-
Binet IV test was administered at 3 and 5 years
of age, the WPPSI-R was used in the current
investigation. Moreover, these results also indi-
cate that the potentially adverse cognitive
effects of blood lead concentrations < 10 µg/dL
persist to 6 years of age—an age when IQ is
Jusko et al.
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Figure 2. Differences in Full-Scale, Performance,
and Verbal IQ associated with increasing lifetime
average blood lead concentrations (n = 174). Mean
IQ levels are adjusted for child’s sex, birth weight,
and transferrin saturation; mother’s race, IQ, and
education level; HOME-SF total score, family
income, and maternal prenatal smoking. Error bars
represent 95% conﬁdence intervals. White bars rep-
resent the mean IQ of children with blood lead con-
centrations < 5 µg/dL (n = 64), the blue bars
represent the mean IQ of children with blood lead
concentrations 5–9.9 µg/dL (n = 70), and the black
bars represent the mean IQ of children with blood
lead concentrations ≥ 10 µg/dL (n = 40). Values
above the brackets represent the mean difference
in IQ for adjacent groups and associated p-values.
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Figure 3. Differences in Full-Scale, Performance,
and Verbal IQ associated with increasing concur-
rent blood lead concentrations (n = 174). Mean IQ
levels are adjusted for child’s sex, birth weight, and
transferrin saturation; mother’s race, IQ, and educa-
tion level; HOME-SF total score, family income, and
maternal prenatal smoking. Error bars represent
95% conﬁdence intervals. White bars represent the
mean IQ of children with blood lead concentrations
< 5 µg/dL (n = 107), the blue bars represent the mean
IQ of children with blood lead concentrations 5–9.9
µg/dL (n = 53), and the black bar represent the mean
IQ of children with blood lead concentrations ≥ 10
µg/dL (n = 14). Values above the brackets represent
the mean difference in IQ for adjacent groups and
associated p-values.
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Figure 4. Differences in Full-Scale, Performance,
and Verbal IQ associated with increasing infancy
average blood lead concentrations (n = 174). Mean
IQ levels are adjusted for child’s sex, birth weight,
and transferrin saturation; mother’s race, IQ, and
education level; HOME-SF total score, family
income, and maternal prenatal smoking. Error bars
represent 95% conﬁdence intervals. White bars rep-
resent the mean IQ of children with blood lead con-
centrations < 5 µg/dL (n = 62), the blue bars
represent the mean IQ of children with blood lead
concentrations 5–9.9 µg/dL (n = 79), and the black
bars represent the mean IQ of children with blood
lead concentrations ≥ 10 µg/dL (n = 33). Values
above the brackets represent the mean difference
in IQ for adjacent groups and associated p-values.
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p = 0.58measured more reliably and is a stronger
predictor of future achievement than when
measured at earlier ages.
A second pattern in our data is that
Performance IQ is more strongly associated
with blood lead levels than is Verbal IQ. This
result is consistent with the ﬁndings from other
cohort studies. In particular, considering the 15
relevant cognitive assessments of children from
3–13 years of age in these studies, 11 ﬁnd blood
lead levels associated with poorer performance
on Performance IQ or related tests of
visual–spatial or visual–motor functioning
(Bellinger et al. 1991; Dietrich et al. 1991,
1992, 1993; Factor-Litvak et al. 1999;
McMichael et al. 1988; Stiles and Bellinger
1993; Tong et al. 1996; Wasserman et al.
1997). For three of the four remaining studies,
one or more key subtests on the Performance
scale (i.e., block design, picture completion,
mazes) were signiﬁcantly associated with chil-
dren’s blood lead concentrations, although the
overall subscale score was not (Baghurst et al.
1992; Stiles and Bellinger 1993; Tong et al.
1996). In one notable exception, no association
with lead exposure was found when children
from the Boston cohort were examined with a
neuropsychological test designed speciﬁcally to
evaluate visual–perceptual and visual–motor
skills in children (Stiles and Bellinger 1993). It
appears that verbal abilities become somewhat
more sensitive indicators only during middle
and later childhood. This runs counter to the
fact that tests of verbal abilities tend to show
slightly greater test–retest reliability than
visual–spatial tests (Sattler 2001).
This study is limited in its ability to
describe fully the blood lead–IQ relation at
concentrations > 10 µg/dL, and thus the esti-
mated mean IQ for children in the ≥ 10 µg/dL
groups may be imprecise. In addition, because
prenatal maternal blood and umbilical cord
blood specimens were unavailable, we were
unable to assess the potential impact of prena-
tal exposures. Though recent evidence suggests
an association between in utero exposures and
neurodevelopment (Hu et al. 2006; Schnaas
et al. 2006), at least two studies reporting on
both pre- and postnatal lead concentrations
nevertheless demonstrate that postnatal lead
concentrations are associated with adverse
neurodevelopmental outcomes, independent of
prenatal lead levels (Schnaas et al. 2006;
Wasserman et al. 2000).
The observational design of this study
makes it necessarily vulnerable to potential
misclassiﬁcation and residual confounding. To
reduce the possibility of misclassification of
exposure, blood lead was assessed up to eight
times during infancy and early childhood.
Compared with cross-sectional studies in
which blood lead concentrations are assessed
at only one time point, multiple lead determi-
nations provide a more complete representa-
tion of children’s exposure to lead, particularly
during the period of 18–36 months of age
when blood lead levels are typically highest
and most variable. To reduce the potential for
residual confounding (Bellinger 2004a), sev-
eral additional covariate measures were exam-
ined in secondary analyses. In addition to the
covariates included in the primary analysis
reported here, we also considered breast-feed-
ing, the HOME scale score at 24 months of
age, and other measures of the child-rearing
environment (crowding in the home, and
household income after accounting for addi-
tional government subsidies and housing
expenses). Some of these covariates were con-
sidered as potential confounders instead of or
in addition to variables in the a priori model,
but their inclusion did not change the esti-
mated mean IQs by > 5%. As a further step to
reduce the potential for residual confounding,
we examined some covariates in polynomial
form and by splines. These methods also did
not materially affect our results. 
The importance of these ﬁndings should be
evaluated in the context of current levels of lead
exposure common in children today. Primarily
because of the elimination of lead as an additive
to paint and gasoline, blood lead levels among
children have declined greatly over the last three
decades: The prevalence of an elevated blood
lead concentration (≥ 10 µg/dL) among all chil-
dren in the United States between 1 and 5 years
of age declined from 77.8% in 1976–1980 to
just 1.6% in 1999–2002 (CDC 2005a). It can
be fairly asked, then: What is the relevance of
our finding that lifetime blood lead levels
between 5 and 10 µg/dL are associated with a
4.9-point decline in IQ? NHANES (National
Health and Nutrition Examination Study) data
from 1988–1994 indicate that approximately
26% of children 1–5 years of age had blood
lead concentrations between 5 and 10 µg/dL
(Bernard and McGeehin 2003). Though this
number probably overestimates the prevalence
today (because of continuing declines in lead
exposure), the proportion of children with
blood lead levels of at least 5 µg/dL but
< 10 µg/dL in some economic, ethnic minority,
and geographic subpopulations is likely to be
much greater (Bernard and McGeehin 2003).
For example, between 1988 and 1994, 1- to
5-year-old children living below the NHANES
poverty income ratio were 60% more likely to
have a blood lead concentration between 5 and
10 µg/dL compared with children living above
the poverty income ratio. From those same
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Figure 5. Differences in Full-Scale, Performance, and
Verbal IQ associated with increasing peak blood
lead concentrations (n = 174). Mean IQ levels are
adjusted for child’s sex, birth weight, and transferrin
saturation; mother’s race, IQ, and education level;
HOME-SF total score, family income, and maternal
prenatal smoking. Error bars represent 95% confi-
dence intervals. The bars represent the mean IQ of
children with blood lead concentrations < 5 µg/dL (n
= 17; white); 5–9.9 µg/dL (n = 79; blue); 10–14.9 µg/dL
(n = 41; black); and ≥ 15 µg/dL (n = 37; gray). Values
above the brackets represent the mean difference in
IQ for adjacent groups and associated p-values.
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Figure 6. Full-Scale IQ as a function of peak blood lead concentration from 6 months to 6 years (n = 169), with
95% confidence intervals. The individual points represent the unadjusted peak blood lead concentrations
and Full-Scale WPPSI-R IQ scores.
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edata, Bernard and McGeehin (2003) estimated
that non-Hispanic black and Mexican-
American children were 3.3 and 2.4 times more
likely to have a blood lead concentration
between 5 and 10 µg/dL, compared with non-
Hispanic white children In addition, 1- to
5-year-olds living in the northeast were
5.8 times more likely to have a blood lead con-
centration between 5 and 10 µg/dL compared
with children living in the western United
States (Bernard and McGeehin 2003).
Important decisions about school place-
ment, aptitude for college work, and opportu-
nities for training and advancement in the
workplace are often based on an individual’s
performance in relation to arbitrary cutoff
scores on IQ-like tests (Bellinger 2004b).
Thus, a small decline in an IQ-like score can
have a profound impact for individuals that
earn scores slightly below an arbitrary cutoff.
Indeed, a difference of only a few points on
an aptitude test prevents many otherwise eli-
gible students from having an opportunity to
pursue higher education. As has been noted
by others (Bellinger 2004b; Gilbert and Weiss
2006; Needleman et al. 1982), the impor-
tance of a small decline in IQ also can be
gauged by taking a societal perspective. For
example, a five-point downward shift in IQ
results in a disproportionate (57%) increase in
the number of children in a population with
IQ scores in the extremely low range (< 70)
(Gilbert and Weiss 2006). An IQ test score of
70 is a commonly used criterion for designat-
ing a child as having mild mental retardation
and is a major consideration in whether or
not a child should be placed in a special edu-
cation program, resulting in an approximate
doubling of the cost for his or her education.
Similarly, a ﬁve-point shift in the average IQ
of a population would lead to a 40% reduc-
tion in the number of children who score in
the very superior range (IQ > 130). An IQ
score of 130 is often a requirement for access
to public school–based programs for gifted
and talented children (Winner 1997). Thus,
when viewed from the perspective of the indi-
vidual and society as a whole, a small effect of
lead on IQ can be very costly. The current
study estimates that effects of this magnitude
may be caused by an increase in blood lead
concentrations from < 5 up to 10 µg/dL.
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